Press Release

Adamas to Present at Upcoming Needham Conference

April 7, 2021 at 5:19 PM EDT

EMERYVILLE, Calif.--(BUSINESS WIRE)--Apr. 7, 2021-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on April 12 – 15, 2021.

The fireside chat will be webcast live on April 14 from 3:00 Eastern Time on the investor relations section of the Adamas website at The replay will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit

Source: Adamas Pharmaceuticals, Inc.

Sarah Mathieson
Vice President, Corporate Communications

Peter Vozzo
Managing Director

Source: Adamas Pharmaceuticals, Inc.